A rare entactogenic drug and analogue of MDMA possibly first synthesised by David Nichols. Potentially less potent than related drugs of its type. Sometimes referred to as a 'watered down MDMA.'.
MBDB molecular structure diagram from the DrugsPRO substance library.
Also known as: Eden, Methyl-j, N-methyl-1-(1,3-benzodioxol- 5-yl)-2-butanamine
Classification
Psychoactive: Entactogen
Psychoactive: Stimulant
Tag: Empathogen
Tag: Habit-Forming
Tag: Research-Chemical
Tag: Tentative
Effects
Increased Heart Rate
Stimulation
Increased Perspiration
Insomnia
Jaw Tension
Teeth Grinding
Talkativeness
Alertness Enhancement
Euphoria
Anxiety
Compulsive Redosing
Motivation Enhancement
Light Sensitivity
Dehydration
Increased Libido
Appetite Suppression
Disinhibition
Vibrating Vision
Routes of Administration
Oral
Dosage
Common: 180-210 mg
Light: 150-180 mg
Strong: 210-250 mg
Duration
No data available for this section yet.
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
This static page is intended as a readable non-JS and prerender-friendly library export.
Get the full DrugsPRO experience
Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.
Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu
MBDB - DrugsPRO aineopas
MBDB: A rare entactogenic drug and analogue of MDMA possibly first synthesised by David Nichols. Potentially less potent than related drugs of its type. Sometimes referred to as a 'watered down MDMA.'.